Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshikazu Nakamura

Showing results (1-10 of 232) with videos related to

Pageof 24
Sort By:
Cells|July 2, 2021
Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 AptamerYoshikazu Nakamura
Seikagaku. the Journal of Japanese Biochemical Society|April 7, 2018
[Regulation and physiological functions of phospholipase C]Yoshikazu Nakamura
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|May 3, 2007
[Life driven by RNA]Yoshikazu Nakamura
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|May 3, 2007
[Translation termination factors and prions]Yoshikazu Nakamura
Biochimie|February 5, 2019
ForewordYoshikazu Nakamura
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|April 17, 2003
[The stream of RNA science]Yoshikazu Nakamura
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|January 12, 2010
[Ribosome world war]Yoshikazu Nakamura
Biochimie|October 21, 2017
Aptamers as therapeutic middle moleculesYoshikazu Nakamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Oligonucleotide therapeutics]Yusaku Matsuda, Yoshikazu Nakamura
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|April 17, 2003
["tRNA mimicry" in translation termination revisited]Koichi Ito, Yoshikazu Nakamura
Pageof 24

Showing results (1-10 of 232) with videos related to

Sort By:
Pageof 24
Cells|July 2, 2021
Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 AptamerYoshikazu Nakamura
Seikagaku. the Journal of Japanese Biochemical Society|April 7, 2018
[Regulation and physiological functions of phospholipase C]Yoshikazu Nakamura
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|May 3, 2007
[Life driven by RNA]Yoshikazu Nakamura
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|May 3, 2007
[Translation termination factors and prions]Yoshikazu Nakamura
Biochimie|February 5, 2019
ForewordYoshikazu Nakamura
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|April 17, 2003
[The stream of RNA science]Yoshikazu Nakamura
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|January 12, 2010
[Ribosome world war]Yoshikazu Nakamura
Biochimie|October 21, 2017
Aptamers as therapeutic middle moleculesYoshikazu Nakamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Oligonucleotide therapeutics]Yusaku Matsuda, Yoshikazu Nakamura
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|April 17, 2003
["tRNA mimicry" in translation termination revisited]Koichi Ito, Yoshikazu Nakamura
Pageof 24